Special Issue "Applied Nanotechnology in Chronic Human Disease Management"
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 8921
Interests: nanoparticles; anti-inflamamtory; anti-cancer; anti-microbials; drug delviery; biomedical engineering; 3D printing
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Environmental Research and Public Health: Oxidative Stress/Antioxidant Research
Special Issue in International Journal of Molecular Sciences: Frontiers in Antimicrobial Materials
Special Issue in International Journal of Molecular Sciences: Advances in Antimicrobial and Macromolecules Materials
Special Issue in Pharmaceutics: Application of Nanoparticles in Cancer Therapy and Diagnosis
Special Issue in International Medical Education: Challenges and Opportunities in Teaching Pharmacology in Medical School
Nanotechnology has been known to produce significant scientific and technological advances in diverse fields, including medicine and physiology. This exciting field of research can be defined as the science and engineering involved in the design, synthesis, characterization, and application of materials and devices whose smallest functional unit is on the nanometer scale, ranging from a few to several hundred nanometers.
The aim of this Special Issue is to include original research and review manuscript describing the preparation, characterization, functionalization, and therapeutic applications in the treatment and diagnosis of chronic human diseases with the objective of improving the therapeutic outcome and quality of life of patients suffering from diseases such as:
- Heart disease
- Chronic lung disease
- Kidney disease
- Inflammatory bowel disease
Authors are invited to submit original and review articles covering all aspects of nanocarriers designed for effective drug delivery and diagnosis.
Dr. Murtaza. M. Tambuwala
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- surface functionalization
- targeted delivery
- natural compounds